Clinical Trials Browser

Phase 2 × ispinesib × Dermatologic × Clear all

NCT00095953 2013-05-17

SB-715992 in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Phase 2 Completed

Melanoma